The offering consists of a parent company with four independent, brick-and-mortar retail pharmacies that offer compounding and custom medication services. The offering also includes a pharmacy management company that operates in-house 340B pharmacies for Federally Qualified Health Clinics and a third-party logistics reverse distribution business in which outdated or overstocked inventory is accepted and managed by return or destruction.
Key Aspects:
• Three synergistic companies in the pharmaceutical supply chain serving multiple Texas communities
• Pharmacy management company that optimizes 340B pharmacies for qualified entities
• Retail pharmacy business with independently branded locations
• Unique reverse logistics segment for prescription medications
• Pharmacies provide a wide range of medication options and consults
• Strong community presence and loyal & established customer base
• Highly functional leadership team that operates the day-to-day and expects to stay on following a sale
Opportunities:
• Expand 340B pharmacy partnerships with Federally Qualifying Health Clinics and Ryan White Clinics
• Optimize the reverse logistics segment of the business by incorporating analytics and reporting into processes
• Capitalize on the closed-door adherence packaged pharmacy trend to cater to at-home senior customer base
• Continue current trend of expansion in order to serve additional geographic markets
Headquartered:
• Texas, US
Current Markets:
• The company serves consumers in multiple cities in Texas and their surrounding areas
Real Estate:
• The business operates from six facilities totaling approximately 26,500 square feet. Five of the locations are owned by current ownership and one is leased from an unrelated third party.
Shareholder Objectives:
• Ownership is seeking a strategic buyer with the ability to either help grow the 340B business or to help optimize the reverse logistics business, or both. Ownership is open to a variety of deal structures in order to facilitate a transaction and would like to provide the opportunity for the core leadership team to buy-in to the new structure and remain with the company.
